Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
N/A
General Information
Revision date
2020-04-15
Product name
Sirolimus Oral Solution 1 mg/L
1.2.2. Uses advised against
No other uses are advised
supplier name
Canada
Icons in SDS
Company Information
company name
Canada
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H361, H372
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION (Fertility or the unborn child) - Category 2 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) (immune system) - Category 1
Signal word
Danger
Hazard statements
H361 - Suspected of damaging fertility or the unborn child. H351 - Suspected of causing cancer. H372 - Causes damage to organs through prolonged or repeated exposure. (immune system)
Precautionary statements
General : Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Do not breathe vapor. Do not eat, drink or smoke when using this product. Wash hands thoroughly after handling.
Response
Get medical attention if you feel unwell. If exposed or concerned: Get medical attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
None known.
